{"issuance_frequency":"","notes_translated":{"fr":"Les promoteurs d’essais cliniques de médicaments et de vaccins liés à la COVID-19 peuvent choisir entre deux processus différents: le processus existant décrit dans le Règlement sur les aliments et drogues; ou le processus décrit dans le nouvel arrêté d’urgence pour les essais cliniques d’instruments médicaux et de médicaments liés à la COVID-19.","en":"Sponsors of COVID-19-related drug and vaccine clinical trials can choose between 2 different processes: existing process outlined in the Food and Drug Regulations or process outlined in the new interim order for clinical trials for medical devices and drugs related to COVID-19."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"dc46508e-2262-48ae-b2a4-2529fa2e6f43","metadata_created":"2021-06-30T17:28:08.589268","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-06-30T17:28:08.589274","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-06-29","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["COVID-19","pandémie","essais cliniques","médicaments","vaccin","demande d'autorisation d'essai","Règlement sur les instruments médicaux","arrêté provisoire pour essais cliniques de médicaments et de vaccins liés à COVID-19"],"en":["COVID-19","pandemic","clinical trials","drugs","vaccine","apply for a trial authorization","Medical Devices Regulations","interim order for clinical trials for drug and vaccine related to COVID-19"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Conduite d'un essai clinique du médicament et du vaccin COVID-19","en":"Conducting a COVID-19 drug and vaccine clinical trial"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"dc46508e-2262-48ae-b2a4-2529fa2e6f43","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"4fd073f5-2fc4-4c38-a39e-074ffc5b2c81","related_relationship":"","name_translated":{"fr":"Conduite d'un essai clinique du médicament et du vaccin COVID-19","en":"Conducting a COVID-19 drug and vaccine clinical trial"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Conducting a COVID-19 drug and vaccine clinical trial","language":["en"],"created":"2021-06-30T17:28:08.677016","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/conducting-clinical-trial.html","last_modified":null,"position":0,"revision_id":"104233d0-47b7-4d0a-bb54-d4b1cf90bf45","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"dc46508e-2262-48ae-b2a4-2529fa2e6f43","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"553cd6a8-2d66-44bc-aee7-90c337657a75","related_relationship":"","name_translated":{"fr":"Conduite d'un essai clinique du médicament et du vaccin COVID-19","en":"Conducting a COVID-19 drug and vaccine clinical trial"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Conducting a COVID-19 drug and vaccine clinical trial","language":["fr"],"created":"2021-06-30T17:28:08.677022","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/liste-essais-cliniques-autorise.html","last_modified":null,"position":1,"revision_id":"104233d0-47b7-4d0a-bb54-d4b1cf90bf45","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2021-05-01 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"dc46508e-2262-48ae-b2a4-2529fa2e6f43","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"Sponsors of COVID-19-related drug and vaccine clinical trials can choose between 2 different processes: existing process outlined in the Food and Drug Regulations or process outlined in the new interim order for clinical trials for medical devices and drugs related to COVID-19.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Conducting a COVID-19 drug and vaccine clinical trial","revision_id":"104233d0-47b7-4d0a-bb54-d4b1cf90bf45"}